40 results
Page 2 of 2
8-K
EX-1.1
5vf5djypp a2a
12 Mar 20
Kala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common Stock
12:00am
8-K
EX-1.1
beyl5fbuhtf s17apk
5 Oct 18
Kala Pharmaceuticals Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
6:01am
424B2
1rqooyyp
3 Oct 18
Prospectus for primary offering
5:26pm
424B2
dvm9vvm aslauzgklm2
2 Oct 18
Prospectus for primary offering
5:26pm
8-K
EX-99.1
exiih bbk3ok
2 Oct 18
Other Events
4:40pm
8-K
EX-10.1
bxj mulqjw
2 Oct 18
Kala Pharmaceuticals Announces Financing from Athyrium Capital Management Totaling $110 Million
4:38pm
S-3
EX-1.2
bo0h 3s9nuotv88j
9 Aug 18
Shelf registration
5:27pm
10-K
qio8m g5fm
2 Apr 18
Annual report
12:00am
10-Q
ee3kt2
31 Aug 17
Quarterly report
12:00am